ClinicalTrials.gg
Drug

Padsevonil clinical trials

Also written UCB0942.

studies test it
14
open now
0
in phase 3
1
first study started
2015

How each study uses padsevonil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Padsevonil
10
PSL
2

Development codes

UCB0942
5

Studies by the year they started

14 studies that test it; most in 2019 (7)

Studies that test padsevonil, by start year
YearStudies
20152
20171
20184
20197

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
4
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 0

UCB Biopharma S.P.R.L. (10) · UCB Biopharma SRL (4)

Often tested with

Tested in the same studies.

Erythromycin (1) · Oxcarbazepine (1)

Studies

Open first, then newest update. How each study uses padsevonil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 14

Codes

What other systems call padsevonil · ClinicalTrials.gg INT001366

  • MeSH (NLM) C000708857padsevonilConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 0R1HN52K0NPADSEVONILConfirmed FDA, NLM, Wikidata
  • Wikidata Q27237119padsevonilConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166432PadsevonilOne source FDA
  • DrugBank DB14977One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.